Cargando…

Recovery from alopecia areata in a patient with autoimmune polyglandular syndrome type 3

Recovery from alopecia is rare in autoimmune polyglandular syndrome (APS). A 41-year-old male was admitted to our hospital with hyperglycemia. He developed alopecia areata (AA) 5 months before admission and developed thirst, polyuria, and anorexia in 2 weeks. His plasma glucose level upon admission...

Descripción completa

Detalles Bibliográficos
Autores principales: Makino, Shinya, Uchihashi, Takeshi, Kataoka, Yasuo, Fujiwara, Masayoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342500/
https://www.ncbi.nlm.nih.gov/pubmed/25759758
http://dx.doi.org/10.1530/EDM-14-0084
_version_ 1782359280944414720
author Makino, Shinya
Uchihashi, Takeshi
Kataoka, Yasuo
Fujiwara, Masayoshi
author_facet Makino, Shinya
Uchihashi, Takeshi
Kataoka, Yasuo
Fujiwara, Masayoshi
author_sort Makino, Shinya
collection PubMed
description Recovery from alopecia is rare in autoimmune polyglandular syndrome (APS). A 41-year-old male was admitted to our hospital with hyperglycemia. He developed alopecia areata (AA) 5 months before admission and developed thirst, polyuria, and anorexia in 2 weeks. His plasma glucose level upon admission was 912 mg/dl (50.63 mmol/l) and HbA1c was 13.7%. Although urinary and plasma C-peptide levels showed that insulin secretion was not depleted, anti-insulinoma-associated antigen 2 antibody was present. In addition, measurement of thyroid autoantibodies revealed the presence of Hashimoto's thyroiditis. These findings suggested a diagnosis of APS type 3. The patient has showed signs of improvement with the continuation of insulin therapy. During the successful control of diabetes, he had total hair regrowth within 2–3 months. Human leukocyte antigen typing showed that DRB1*1501-DQB1*0602 and DQB1*0301 were present. Similar cases should be accumulated to clarify the association of APS type 3 with recovery from AA. LEARNING POINTS: Alopecia in diabetic patients is a suspicious manifestation of autoimmune type 1 diabetes. Patients with autoimmune type 1 diabetes specifically manifesting alopecia should be further examined for diagnosis of APS. Insulin-mediated metabolic improvement may be a factor, but not the sole factor, determining a favorable outcome of alopecia in patients with autoimmune type 1 diabetes.
format Online
Article
Text
id pubmed-4342500
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Bioscientifica Ltd
record_format MEDLINE/PubMed
spelling pubmed-43425002015-03-10 Recovery from alopecia areata in a patient with autoimmune polyglandular syndrome type 3 Makino, Shinya Uchihashi, Takeshi Kataoka, Yasuo Fujiwara, Masayoshi Endocrinol Diabetes Metab Case Rep Unique/Unexpected Symptoms or Presentations of a Disease Recovery from alopecia is rare in autoimmune polyglandular syndrome (APS). A 41-year-old male was admitted to our hospital with hyperglycemia. He developed alopecia areata (AA) 5 months before admission and developed thirst, polyuria, and anorexia in 2 weeks. His plasma glucose level upon admission was 912 mg/dl (50.63 mmol/l) and HbA1c was 13.7%. Although urinary and plasma C-peptide levels showed that insulin secretion was not depleted, anti-insulinoma-associated antigen 2 antibody was present. In addition, measurement of thyroid autoantibodies revealed the presence of Hashimoto's thyroiditis. These findings suggested a diagnosis of APS type 3. The patient has showed signs of improvement with the continuation of insulin therapy. During the successful control of diabetes, he had total hair regrowth within 2–3 months. Human leukocyte antigen typing showed that DRB1*1501-DQB1*0602 and DQB1*0301 were present. Similar cases should be accumulated to clarify the association of APS type 3 with recovery from AA. LEARNING POINTS: Alopecia in diabetic patients is a suspicious manifestation of autoimmune type 1 diabetes. Patients with autoimmune type 1 diabetes specifically manifesting alopecia should be further examined for diagnosis of APS. Insulin-mediated metabolic improvement may be a factor, but not the sole factor, determining a favorable outcome of alopecia in patients with autoimmune type 1 diabetes. Bioscientifica Ltd 2015-02-01 2015 /pmc/articles/PMC4342500/ /pubmed/25759758 http://dx.doi.org/10.1530/EDM-14-0084 Text en © 2015 The authors This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License (http://creativecommons.org/licenses/by/3.0/deed.en_GB) .
spellingShingle Unique/Unexpected Symptoms or Presentations of a Disease
Makino, Shinya
Uchihashi, Takeshi
Kataoka, Yasuo
Fujiwara, Masayoshi
Recovery from alopecia areata in a patient with autoimmune polyglandular syndrome type 3
title Recovery from alopecia areata in a patient with autoimmune polyglandular syndrome type 3
title_full Recovery from alopecia areata in a patient with autoimmune polyglandular syndrome type 3
title_fullStr Recovery from alopecia areata in a patient with autoimmune polyglandular syndrome type 3
title_full_unstemmed Recovery from alopecia areata in a patient with autoimmune polyglandular syndrome type 3
title_short Recovery from alopecia areata in a patient with autoimmune polyglandular syndrome type 3
title_sort recovery from alopecia areata in a patient with autoimmune polyglandular syndrome type 3
topic Unique/Unexpected Symptoms or Presentations of a Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342500/
https://www.ncbi.nlm.nih.gov/pubmed/25759758
http://dx.doi.org/10.1530/EDM-14-0084
work_keys_str_mv AT makinoshinya recoveryfromalopeciaareatainapatientwithautoimmunepolyglandularsyndrometype3
AT uchihashitakeshi recoveryfromalopeciaareatainapatientwithautoimmunepolyglandularsyndrometype3
AT kataokayasuo recoveryfromalopeciaareatainapatientwithautoimmunepolyglandularsyndrometype3
AT fujiwaramasayoshi recoveryfromalopeciaareatainapatientwithautoimmunepolyglandularsyndrometype3